Navigation Links
AstraZeneca Donates $3.8 million in Medicines for U.S. Free Clinics

STAMFORD, Conn., Jan. 24, 2012 /PRNewswire-USNewswire/ -- AstraZeneca, the global biopharmaceutical company, has donated $3.8 million worth of prescription medicines to AmeriCares for chronically ill Americans who rely on safety net clinics for their medical care. The donation is one of the largest AmeriCares received in the past year for its domestic aid deliveries.

AmeriCares is delivering the medicines to free clinics and community health centers through its U.S. Medical Assistance Program, which provides free medicines and medical supplies to 400 health care facilities serving the poor and uninsured across the United States. The AstraZeneca products are expected to benefit patients of about 100 clinics in 28 states.

"The medicines donated by AstraZeneca are among the most frequently requested products by our partner clinics," said Morgan White, manager of AmeriCares U.S. Medical Assistance Program. "Thanks to our partnership with AstraZeneca, we are helping the most vulnerable Americans."

Among the clinics receiving AstraZeneca products are:

  • The Way Free Medical Clinic in Florida, where patients have been hard hit by the collapse of the housing market.
  • Traverse Health Clinic in Michigan, where the unemployment rate is one of the highest in the nation.
  • Sacred Heart Community Clinic in Texas, where 25 percent of state residents are uninsured – the highest rate in the country.

Christy Fitzgerald, executive director of The Way Free Medical Clinic in Green Cove Springs, Fla., which received nearly $50,000 worth of AstraZeneca medicines, said the donation has greatly helped patients in the construction industry who have lost jobs or had their hours cut and can no longer afford health insurance. The asthma medicines have been particularly beneficial, she said, because they have allowed the clinic to begin treating patients on the spot.

"Donations like this one are critical because we could never afford to purchase these medicines for our patients," Fitzgerald said.

This is the third consecutive year AstraZeneca has supported AmeriCares aid deliveries in the U.S. with a major donation. The company also supports AmeriCares global disaster response work and aid deliveries in the developing world with product donations. Since 2003, AstraZeneca has donated essential medicines to AmeriCares valued at more than $63 million.

About AmeriCares
AmeriCares is a nonprofit global health and disaster relief organization which delivers medicines, medical supplies and aid to people in need around the world and across the United States. Since it was established in 1982, AmeriCares has distributed more than $10 billion in humanitarian aid to 164 countries. For more information, visit

Donna Porstner: Office (203) 658-9579
Cell (516) 607-1180

SOURCE AmeriCares
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
2. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
3. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
4. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
5. AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
6. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
7. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
8. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
9. AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
10. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
11. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
Post Your Comments:
(Date:11/26/2015)... 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ... kidney transplantation is expected to boost the market growth, as ... transplantation. --> 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/26/2015)... Research and Markets ( ) has ... Market by Type (Dressings, Therapy Devices, Active Wound Care), ... Facility), and Geography - Global Forecast to 2020" ... --> The purpose of this report ... the global advanced wound care market. It involves deep ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 2015 , ... The holiday season is jam-packed with family ... of attendees is of the utmost importance. Whether you are cooking at home ... recipes a try this holiday season. , Turkey Croquettes ,     Ingredients: ...
(Date:11/25/2015)... ... 2015 , ... Ministers, senior government and UN agencies, representatives ... of Excellence, and public R&D institutions, civil societies and other partners gathered today ... African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- day ...
(Date:11/25/2015)... ... 25, 2015 , ... Dental professionals who would like to become more proficient ... attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held ... the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens ... Bruxism, and moderate facial wrinkling. While many patients are aware of the benefits of ... success Botox® delivers to those suffering with discomfort, soreness, and pain as a result ...
(Date:11/25/2015)... , ... November 25, 2015 , ... “While riding the ... inventor, from Bronx, N.Y. “I thought there had to be a convenient and comfortable ... PROTECTOR. , The PROTECTOR enables disabled individuals to safely travel during cold or inclement ...
Breaking Medicine News(10 mins):